Sunshine Biopharma Inc. (SBFMW) Capital expenditures 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$174,491FY2025 · since FY2016: $3,439 → $174,491
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $174,491 | -89.5% |
| FY2024 | $1.7M | +1914.6% |
| FY2023 | $82,251 | -57.6% |
| FY2022 | $193,982 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $1,191 | +38.5% |
| FY2019 | $860 | -95.4% |
| FY2018 | $18,850 | +407.0% |
| FY2017 | $3,718 | +8.1% |
| FY2016 | $3,439 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →